BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20160101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170906
DTEND;VALUE=DATE:20170908
DTSTAMP:20260515T132410
CREATED:20170502T034747Z
LAST-MODIFIED:20170502T040051Z
UID:1574-1504656000-1504828799@www.pharmajournalist.com
SUMMARY:2nd European Prefilled Syringes Summit
DESCRIPTION:After the success of our first European Prefilled Syringes Summit\, we are pleased to announce the next edition which shall take place on the 6th & 7th September in Berlin\, Germany. \n \nACI’s European Prefilled Syringes Summit will explore the advancements in regulatory guidelines\, product development\, manufacturing processes\, risk mitigation \, portfolio management and answer some infinite industry questions such as; how the industry is responding to disruptive technology\, connectivity\, speed to market\, and next generation syringes. There are several elements that pose a severe challenge to the growth of the global prefilled syringes market\, the primary one being the high costs associated with temperature controlled packaging required for temperature-sensitive drugs. Other more traditional factors inhibiting the market include product recalls due to breakages and leachables\, the potential risk of interaction between prefilled syringes and drugs\, and needle stick prevention. \nKey Topics Include:  \n\nEuropean prefilled syringes market & growth opportunities\nTrends in modern biologics targeting therapeutic classes of drugs that are considered to be the primary growth drivers within the market\nLatest FDA guidelines in receiving PFS & overcoming complex requirements for approval\nSpecialty syringes\, which include prefilled flush syringes\, prefilled diluent systems and contrast agents in prefilled syringe\nConcentrating on Next Generation Smart Devices while Overcoming Traditional Challenges\nManaging the Materials used to Construct Pre-Filled Syringes—Selection and Supply Chain Control\nBalancing biopharmaceutical product portfolio for continual product innovation\, such as incorporating a new delivery component and Creating a lower-risk product development strategy\nUsability: Key Human Factor Attributes & Interactive Considerations.\nThe Drug/Device interface: Integration of the formulation and the device \n\n15% subscriber’s discount available on the registration fee.  \nTo receive the agenda or for the priority registration\, please contact\nMohammad Ahsan on +44 (0)20 3141 0606 or email: mahsan@acieu.net \nConference Fee:               £1\,595 (£240 Discount for all members/subscribers) \nDownload the Brochure : http://www.wplgroup.com/aci/wp-content/uploads/sites/2/2017/03/PPFE2-Agenda_MKT.pdf \nDownload the Brochure Now!
URL:https://www.pharmajournalist.com/event/2nd-european-prefilled-syringes-summit/
LOCATION:Berlin\, Germany\, India
ORGANIZER;CN="Active Communications Europe Ltd (ACI)":MAILTO:mahsan@acieu.net
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170906
DTEND;VALUE=DATE:20170908
DTSTAMP:20260515T132410
CREATED:20170623T033647Z
LAST-MODIFIED:20170623T033647Z
UID:2374-1504656000-1504828799@www.pharmajournalist.com
SUMMARY:Outsourcing in Clinical Trials New England
DESCRIPTION:OCT New England returns to Boston this September with an agenda that hosts new session formats including an ideal pool\, lightning round and workshops. Last year the event saw countless attendees engage in thought leadership presentations and interactive discussions which enabled relationship building and the creation of long lasting relationships. The agenda will address many key themes such as managing vendor contracts and overcoming the challenges of using mobile devices in trials.  \nWe invite you to join us for an event that is promised to be bigger and better than ever. Simply visit the website today to register online http://www.arena-international.com/octnewengland/  
URL:https://www.pharmajournalist.com/event/outsourcing-clinical-trials-new-england/
LOCATION:Boston\, MA
ORGANIZER;CN="Arena International":MAILTO:sarah.rosenberg@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170907
DTEND;VALUE=DATE:20170909
DTSTAMP:20260515T132410
CREATED:20170619T035153Z
LAST-MODIFIED:20170619T035851Z
UID:2282-1504742400-1504915199@www.pharmajournalist.com
SUMMARY:Life Science Investor Relations Forum
DESCRIPTION:Exl’s Life Science IR Forum\, taking place on September 7-8\, 2017 at the Revere Hotel in Boston\, MA\, will bring together IR professionals to address the diverse set of challenges faced in the life sciences industry. Our expert speaking faculty will provide thought-provoking dialogue paired with networking opportunities that no other conferences address. IR teams are continuously balancing new regulations\, advancements in technology\, more engaged investors and working relationships with advisory boards. Through this event\, IR specialists will be able to efficiently gain the knowledge they need to improve their programs while developing a new network of educated IR colleagues. \nTo learn more about this event\, and to register online\, visit http://bit.ly/2rMkxvl
URL:https://www.pharmajournalist.com/event/life-science-investor-relations-forum/
LOCATION:Revere Hotel Boston Common\, 200 Stuart St\, Boston\, MA 02116
ORGANIZER;CN="ExL Events":MAILTO:cbrady@exlevents.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170912
DTEND;VALUE=DATE:20170914
DTSTAMP:20260515T132410
CREATED:20170718T040342Z
LAST-MODIFIED:20170718T040609Z
UID:2505-1505174400-1505347199@www.pharmajournalist.com
SUMMARY:Clinical Trial Supply Midwest 2017
DESCRIPTION: This unique event brings together leading pharma\, device and biotech professionals from across the Midwest region. After a hugely successful launch event in 2016\, the Clinical Trials Supply Midwest Conference will be returning to Chicago for its 2nd edition\, with more content and senior level speakers than before. The Clinical Trial Supply stream will also now be run across the full 2 days due to increased demand.
URL:https://www.pharmajournalist.com/event/clinical-trial-supply-midwest-2017/
LOCATION:Chicago\, Illinois (Venue TBC)
ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170925
DTEND;VALUE=DATE:20170928
DTSTAMP:20260515T132410
CREATED:20170620T091806Z
LAST-MODIFIED:20170620T092213Z
UID:2329-1506297600-1506556799@www.pharmajournalist.com
SUMMARY:FierceBiotech 2nd Drug Development Forum
DESCRIPTION:The 2nd annual FierceBiotech Drug Development Forum will draw together the industry’s executive decision-makers\, to help guide your companies to success throughout the entire life cycle – both for products and for companies themselves. This event gives biopharma leaders the skills to improve their partnership strategies with larger companies\, financing sources and outsourced research partners. Our experienced and savvy executive-level speaking faculty will help you shape\, select and pitch the best partnerships for drug development\, while successfully navigating the financial and regulatory changes arising from a new administration. Target your learning opportunities toward four full-length tracks: Strategic Deal-Making\, Clinical Research Outsourcing & Technology\, Improving R&D Outcomes and Digital Technology & Real-World Evidence. We invite you to join this unparalleled opportunity to work with your peers toward a quantum leap in drug development productivity and speed! \nTo learn more about this event\, and to register online\, visit http://bit.ly/2sOSHSE
URL:https://www.pharmajournalist.com/event/fiercebiotech-2nd-drug-development-forum/
LOCATION:Renaissance Boston Waterfront Hotel\, 606 Congress Street\, Boston\, MA 02210
ORGANIZER;CN="ExL Events":MAILTO:amagnolo@exlevents.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170925
DTEND;VALUE=DATE:20170930
DTSTAMP:20260515T132410
CREATED:20170626T071104Z
LAST-MODIFIED:20170627T074854Z
UID:2392-1506297600-1506729599@www.pharmajournalist.com
SUMMARY:15th Annual Global Forum
DESCRIPTION:Returning for its 15th iteration\, the world’s largest event for temperature-controlled life science supply chains heads back to Chicago this year with a focus on the next generation of temperature control! Join 850+ attendees from 30+ countries for five days of master classes\, workshops\, track sessions\, panel discussions\, roundtables\, and more.  With the Global Forum\, your company will meet emerging and ongoing challenges for 2017 and beyond. \nTo learn more about this event visit http://bit.ly/2tKDbVk \nDownload the Event Agenda: http://bit.ly/2taKpon \nTo register please visit http://bit.ly/2sQSeN9
URL:https://www.pharmajournalist.com/event/15th-annual-global-forum/
LOCATION:Hyatt Regency McCormick Place\, Chicago\, IL
ORGANIZER;CN="IQPC North America":MAILTO:enquiry@iqpc.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170926
DTEND;VALUE=DATE:20170928
DTSTAMP:20260515T132410
CREATED:20170817T001521Z
LAST-MODIFIED:20170817T002251Z
UID:2889-1506384000-1506556799@www.pharmajournalist.com
SUMMARY:BioPharm America™ 2017
DESCRIPTION:BioPharm America™ 2017—10th Annual International Partnering Conference\nAccess capital\, innovation and partners \nBioPharm America™ is a unique partnering event that forms the nexus of discovery and realization. Now in its tenth year\, BioPharm America creates a robust exchange among hundreds of executives from venture capital firms\, major pharmaceutical companies\, academic institutions and biotechnology companies of every size and stage\, from mature to startup. The event brings dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development. \n \nA primary focus of BioPharm America™ is the one-to-one meetings driven by partneringONE®\, the industry’s most robust software platform. Delegates can request and schedule meetings tailored to their strategic business goals to create a dynamic personalized agenda that includes regular alerts for further meeting opportunities. \nThe impetus behind this intensive business development activity is a two-day \nconference program that features thought leaders and executives from across the life science industry. To help bring attention to early stage projects and small entrepreneurial companies\, BioPharm America features special tracks specifically designed for startups and young companies to get on the radar of the global life science community and to make the connections that matter. Engaging panel discussions cover topics of interest to dealmakers including licensing\, investment and business development. \nLeading pharmaceutical companies attend BioPharm America in search of innovation\, such as Amgen\, AstraZeneca\, Bayer HealthCare\, Biogen Idec\, Boehringer Ingelheim\, Genentech\, Sanofi/Genzyme\, Gilead\, Ironwood\, Johnson & Johnson Innovation\, Merck\, Novo Nordisk\, Nycomed\, Pfizer\, and Shire. Held in Boston each September\, the event attracted 850+ delegates from 525 companies who participated in 2\,350+ scheduled one-to-one meetings in 2016. \nTo learn more about this event\, and to register online\, visit https://goo.gl/SZfnmi \nProducer: \nEBD Group\, Inc.\nEBD Group is an Informa company. Informa is the largest publicly-owned organizer of exhibitions\, conferences and training in the world.  \nContact: \nCassidy Hamilton\nEBD Group\nCarlsbad\, CA\n+1 760 930 0500\nchamilton@ebdgroup.com \n 
URL:https://www.pharmajournalist.com/event/biopharm-america-2017/
LOCATION:Sheraton Boston Hotel\, 39 Dalton Street\, Boston\, MA\, 02199\, United States
ORGANIZER;CN="EBD Group%2C Inc.":MAILTO:chamilton@ebdgroup.com
END:VEVENT
END:VCALENDAR